US Patent 11008337 Chiral diaryl macrocycles as modulators of protein kinases
Patent 11008337 was granted and assigned to Turning Point Therapeutics on May, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+113 characters)
Article
Patent abstract
The present disclosure relates to certain chiral diaryl macrocyclic derivatives, of the formula I:
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 2 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110083370
Date of Patent
May 18, 2021
0Patent Application Number
164254070
Date Filed
May 29, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110083370
Date of Patent
May 18, 2021
0Patent Application Number
164254070
Date Filed
May 29, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Golden AI
Infobox
Patent Citations
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+13 properties)
US Patent 11008337 Chiral diaryl macrocycles as modulators of protein kinases
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11008337
Date of patent
May 18, 2021
Patent application number
16425407
Date Filed
May 29, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 11008337 Chiral diaryl macrocycles as modulators of protein kinases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
